Vimarsana
Biggest News Aggregation in the World

Page 13 - Altimmune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Altimmune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Altimmune Today - Breaking & Trending Today

$2.06 Million in Sales Expected for Altimmune, Inc. (NASDAQ:ALT) This Quarter - Vimarsana News

$2.06 Million in Sales Expected for Altimmune, Inc. (NASDAQ:ALT) This Quarter

Wall Street analysts expect Altimmune, Inc. (NASDAQ:ALT – Get Rating) to report $2.06 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Altimmune’s earnings. The lowest sales estimate is $200,000.00 and the highest is $5.00 million. Altimmune reported sales of $840,000.00 during the same quarter last […]

Altimmune, Inc. (NASDAQ:ALT) Expected to Post Quarterly Sales of $2.06 Million - Vimarsana News

Altimmune, Inc. (NASDAQ:ALT) Expected to Post Quarterly Sales of $2.06 Million

Brokerages expect that Altimmune, Inc. (NASDAQ:ALT – Get Rating) will post sales of $2.06 million for the current quarter, Zacks reports. Three analysts have made estimates for Altimmune’s earnings, with estimates ranging from $200,000.00 to $5.00 million. Altimmune reported sales of $840,000.00 in the same quarter last year, which would suggest a positive year over […]

Altimmune (NASDAQ:ALT) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS - Vimarsana News

Altimmune (NASDAQ:ALT) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Altimmune (NASDAQ:ALT – Get Rating) issued its quarterly earnings results on Tuesday. The company reported ($0.57) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.64) by $0.07, MarketWatch Earnings reports. Altimmune had a negative return on equity of 36.90% and a negative net margin of 2,200.61%. During the same quarter […]

Altimmune, Inc. (NASDAQ:ALT) to Post FY2022 Earnings of ($2.34) Per Share, Jefferies Financial Group Forecasts - Vimarsana News

Altimmune, Inc. (NASDAQ:ALT) to Post FY2022 Earnings of ($2.34) Per Share, Jefferies Financial Group Forecasts

Altimmune, Inc. (NASDAQ:ALT – Get Rating) – Equities researchers at Jefferies Financial Group cut their FY2022 EPS estimates for Altimmune in a research note issued to investors on Tuesday, March 15th. Jefferies Financial Group analyst R. Song now anticipates that the company will post earnings of ($2.34) per share for the year, down from their […]

Q1 2022 Earnings Forecast for Altimmune, Inc. (NASDAQ:ALT) Issued By Piper Sandler - Vimarsana News

Q1 2022 Earnings Forecast for Altimmune, Inc. (NASDAQ:ALT) Issued By Piper Sandler

Altimmune, Inc. (NASDAQ:ALT – Get Rating) – Stock analysts at Piper Sandler lifted their Q1 2022 earnings per share (EPS) estimates for shares of Altimmune in a research note issued to investors on Tuesday, March 15th. Piper Sandler analyst Y. Rahimi now expects that the company will post earnings per share of ($0.70) for the […]